BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21898084)

  • 1. Clinical characteristics, nocturnal antidiuretic hormone levels, and responsiveness to DDAVP of school children with primary nocturnal enuresis.
    Chang JW; Yang LY; Chin TW; Tsai HL
    World J Urol; 2012 Aug; 30(4):567-71. PubMed ID: 21898084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of desmopressin in the management of nocturnal enuresis in patients with spinal cord injury.
    Zahariou A; Karagiannis G; Papaioannou P; Stathi K; Michail X
    Eura Medicophys; 2007 Sep; 43(3):333-8. PubMed ID: 17021585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A randomized controlled clinical trial for treatment of children with primary nocturnal enuresis].
    Ma J; Zhang YW; Wu H; Jiang F; Jin XM
    Zhonghua Er Ke Za Zhi; 2007 Mar; 45(3):167-71. PubMed ID: 17504616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis.
    Hara T; Ohtomo Y; Endo A; Niijima S; Yasui M; Shimizu T
    J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin response in nocturnal enuresis showing concentrated urine.
    Akagawa S; Tsuji S; Akagawa Y; Yamanouchi S; Kimata T; Kaneko K
    Pediatr Int; 2020 Jun; 62(6):701-704. PubMed ID: 32065484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term desmopressin response in primary nocturnal enuresis: open-label, multinational study.
    Lottmann H; Baydala L; Eggert P; Klein BM; Evans J; Norgaard JP
    Int J Clin Pract; 2009 Jan; 63(1):35-45. PubMed ID: 19125991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiuretic hormone regulation in patients with primary nocturnal enuresis.
    Eggert P; Kühn B
    Arch Dis Child; 1995 Dec; 73(6):508-11. PubMed ID: 8546506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High daily salt intake had a negative impact on how well nocturnal enuresis treatment worked on children aged 7-10 years.
    Tsuji S; Yamaguchi T; Akagawa Y; Akagawa S; Kino J; Yamanouchi S; Kimata T; Kaneko K
    Acta Paediatr; 2020 Jan; 109(1):193-197. PubMed ID: 31254367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The circadian defect in plasma vasopressin and urine output is related to desmopressin response and enuresis status in children with nocturnal enuresis.
    Rittig S; Schaumburg HL; Siggaard C; Schmidt F; Djurhuus JC
    J Urol; 2008 Jun; 179(6):2389-95. PubMed ID: 18433780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spina bifida occulta: not to be overlooked in children with nocturnal enuresis.
    Shin SH; Im YJ; Lee MJ; Lee YS; Choi EK; Han SW
    Int J Urol; 2013 Aug; 20(8):831-5. PubMed ID: 23294087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
    Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
    J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of intranasal DDAVP therapy in children with nocturnal enuresis.
    Shu SG; Lii YP; Chi CS
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Dec; 52(6):368-71. PubMed ID: 8299037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.
    Berkenwald A; Pires J; Ellsworth P
    J Pediatr Urol; 2016 Aug; 12(4):220.e1-6. PubMed ID: 27373215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 1-deamino 8-D-arginine vasopressin spray on nasal cytology and mucociliary clearance in patients with nocturnal enuresis.
    Akoğlu E; Görür S; Atik E; Okuyucu S; Sangün O
    Int J Pediatr Otorhinolaryngol; 2006 Nov; 70(11):1919-22. PubMed ID: 16901550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit/hyperactivity disorder and enuresis: a study about effectiveness of treatment with methylphenidate or desmopressin in a pediatric population.
    Ferrara P; Sannicandro V; Ianniello F; Quattrocchi E; Sbordone A; Petitti T; Mariotti P
    Minerva Pediatr; 2019 Apr; 71(2):135-138. PubMed ID: 28260347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of long-term desmopressin and alarm treatment for bedwetting.
    Evans J; Malmsten B; Maddocks A; Popli HS; Lottmann H;
    J Pediatr Urol; 2011 Feb; 7(1):21-9. PubMed ID: 20579938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic nocturnal enuresis.
    Kamperis K; Rittig S; Radvanska E; Jørgensen KA; Djurhuus JC
    J Urol; 2008 Aug; 180(2):707-13; discussion 713-4. PubMed ID: 18554642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of DDAVP is related to the circadian rhythm of urine output in patients with persisting nocturnal enuresis.
    Hunsballe JM; Hansen TK; Rittig S; Pedersen EB; Djurhuus JC
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):793-801. PubMed ID: 10209568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmopressin oral lyophilisate in young children: new insights in pharmacokinetics and pharmacodynamics.
    Dossche L; Michelet R; De Bruyne P; Van Herzeele C; Gasthuys E; Rittig S; Vermeulen A; Vande Walle J
    Arch Dis Child; 2021 Jun; 106(6):597-602. PubMed ID: 32737054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary monosymptomatic nocturnal enuresis in children and adolescents.
    Lottmann HB; Alova I
    Int J Clin Pract Suppl; 2007 Sep; (155):8-16. PubMed ID: 17727574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.